Tianjin Tianyao Pharmaceuticals Co.,Ltd established on December 1, 1999. (formerly known as Tianjin Pharmaceutical Factory, founded in 1939), is the holding enterprise of Tianjin Pharmaceutical Holdings Co.,Ltd. The company is a national high-tech enterprise. It is the research, manufacture and export base for corticosteroid bulks in Asia.
Prednisone, Dexamethasone, Methylprednisolone, Spironolactone, Dexamethasone Sodium Phosphate, Betamethasone, Methylprednisolone Acetate, Prednisone Acetate, Prednisolone, Triamcinolone Acetonide, Celecoxib, Methylprednisolone Tablets, Prednisone Tablet, Celecoxib Capsule have approved by US FDA. Budesonide, Prednisolone, Prednisone, Hydrocortisone Acetate, Methylprednisolone, Spironolactone, Dexamethasone Sodium Phosphate, Dexamethasone, L-valine have approved by EDQM. Dexamethasone series have passed the W.H.O. Pre-Certification for collectible Harvest Products. API products are exported to more than 70 countries and regions. The annual production capacity of corticosteroid API exceeds 200 tons.
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight January 2025
